Incremental syringe
11464913 · 2022-10-11
Assignee
Inventors
- Majid Mirzazadeh (Winston-Salem, NC, US)
- Phillip J. Brown (Winston-Salem, NC, US)
- Kenneth W. Russell (Winston-Salem, NC, US)
Cpc classification
A61M5/3157
HUMAN NECESSITIES
A61M5/31513
HUMAN NECESSITIES
A61M5/31526
HUMAN NECESSITIES
A61M5/31595
HUMAN NECESSITIES
International classification
Abstract
An incremental syringe useful for multiple injections of medications like botulinum toxin is provided. The syringe includes detents on the syringe plunger which provide a tactile feeling, a discrete audible sound or “click,” or preferably both, for every unit of medication aspirated or injected to or from an individual syringe. Hence, there is no need to look at the syringe, or bring it to the eye level, during use thereof. In some embodiments, a second set of detents is included, and in some embodiments a third set of detents is included. Syringe plungers useful for combining with a syringe body to produce such an incremental syringe are also described.
Claims
1. A syringe, comprising: (a) an elongate hollow body having a first open end, an inside wall, a second open end, and a continuous annular raised lip on the inside wall; and (b) a syringe plunger positioned in the elongate hollow body through the second open end, the syringe plunger comprising: (i) an elongate shaft having a longitudinal axis, an upper end portion and a lower end portion; (ii) a seal connected to the lower end portion; (iii) a plurality of elongate ribs joined along the longitudinal axis, each rib comprising opposing side portions and an elongate edge portion; and (iv) a first set of detent subsets and a second set of detent subsets formed on the elongate shaft, wherein the first set of detent subsets and the second set of detent subsets are configured to releasably engage the continuous annular raised lip when the syringe plunger is moved within the elongate hollow body, wherein the syringe has a total volume, the first set of detent subsets and the second set of detent subsets are configured to divide the total volume into a plurality of separate subvolumes, and wherein the first set of detent subsets and the second set of detent subsets each comprise: a first detent, a second detent, and a trapping segment disposed between the first and second detents, wherein the first set of detent subsets extend from the elongate edge portion of a first elongate rib of the plurality of elongate ribs and the second set of detent subsets extend from the elongate edge portion of a second elongate rib of the plurality of ribs, the first set of detent subsets is longitudinally offset from the second set of detent subsets.
2. The syringe of claim 1, wherein the first detent comprises a leading edge portion and a trailing edge portion, wherein a slope of the trailing each portion is greater than a slope of the leading edge portion.
3. The syringe of claim 1, wherein the second detent comprises a leading edge portion and a trailing edge portion, wherein a slope of the leading edge portion is greater than a slope of the trailing edge portion.
4. The syringe of claim 1, wherein the first and second detents are disc-shaped.
5. The syringe of claim 1, wherein the continuous annular raised lip is disposed within the trapping segment following injection of the subvolume.
6. The syringe of claim 1, wherein the first and second sets of detent subsets are formed on the elongate shaft in a linear and uniformly spaced pattern thereon aligned with the longitudinal axis, wherein the second set of detent subsets is positioned in offset alignment with the first set of detent subsets, and wherein the first and second sets of detent subsets together are configured to define on the elongate shaft: (i) a plurality of uniformly sized, injection segments, and (ii) a plurality of uniformly sized trapping segments in a sequential alternating arrangement with the injection segments.
7. The syringe of claim 1, wherein the first set of detent subsets is configured to provide an audible and/or tactile click to a user as forward motion of the syringe plunger into the elongate hollow body causes the first detent of the first set of detent subsets to encounter and pass the continuous annular raised lip.
8. The syringe of claim 1, further comprising: a third set of uniformly spaced, fixed raised detent subsets formed on the elongate shaft and positioned to aid in arresting forward motion of the syringe plunger just after a first detent of the third set of detent subsets elicits an audible and/or tactile “click” upon passage by the continuous annular raised lip.
9. The syringe plunger of claim 8, wherein the first, second, and third sets of detent subsets are configured to sequentially and releasably engage the continuous annular raised lip of the elongate hollow body when the syringe plunger is longitudinally displaced relative to the elongate hollow body.
10. The syringe of claim 1, wherein the elongate shaft and the elongate hollow body comprise an organic polymer.
11. The syringe of claim 1, wherein the continuous annular raised lip is positioned adjacent the second open end.
12. The syringe of claim 1, the syringe having a total injectable volume of from 1 milliliter to 10 milliliters, wherein the first set of detent subsets and the second set of detent subsets are configured to divide the total injectable volume into from 10 uniform injectable subvolumes to 50 uniform injectable subvolumes.
13. A syringe plunger comprising: (i) an elongate shaft having a longitudinal axis, an upper end portion and a lower end portion; (ii) a seal connected to the lower end portion; (iii) a plurality of elongate ribs joined along the longitudinal axis, each rib comprising opposing side portions and an elongate edge portion; and (iv) a first set of detent subsets and a second set of detent subsets formed on the elongate shaft aligned with the longitudinal axis; and wherein each of the first set of detent subsets and the second set of detent subsets comprise: a first detent, a second detent, and a trapping segment disposed between the first and second detents, wherein the first set of detent subsets extend from the elongate edge portion of a first elongate rib of the plurality of elongate ribs and the second set of detent subsets extend from the elongate edge portion of a second elongate rib of the plurality of ribs, the first set of detent subsets is longitudinally offset from the second set of detent subsets.
14. The syringe plunger of claim 13, wherein the first set of detent subsets and the second set of detent subsets are configured to sequentially and releasably engage a continuous annular raised lip of a syringe body when the syringe plunger is longitudinally displaced relative to the syringe body.
15. The syringe plunger of claim 13, wherein the first set of detent subsets and the second set of detent subsets are uniformly and longitudinally spaced along the elongate shaft.
16. The syringe plunger of claim 13, wherein the first detent comprises a leading edge portion and a trailing edge portion, wherein a slope of the trailing each portion is greater than a slope of the leading edge portion, and wherein the second detent comprises a leading edge portion and a trailing edge portion, wherein a slope of the leading edge portion is greater than a slope of the trailing edge portion.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
(27)
(28)
(29)
(30)
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
(31) The present invention is now described more fully hereinafter with reference to the accompanying drawings, in which embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Instead, these embodiments are provided so that this disclosure will be efficiently convey non-limiting examples of the invention to those skilled in the art.
(32) Like numbers refer to like elements throughout. In the figures, the thickness of certain lines, layers, components, elements or features may be exaggerated for clarity. Where used, broken lines illustrate optional features or operations unless specified otherwise.
(33) The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms “a,” “an” and “the” are intended to include plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” or “comprising,” when used in this specification, specify the presence of stated features, integers, steps, operations, elements components and/or groups or combinations thereof, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components and/or groups or combinations thereof.
(34) As used herein, the term “and/or” includes any and all possible combinations or one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative (“or”).
(35) Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the specification and claims and should not be interpreted in an idealized or overly formal sense unless expressly so defined herein. Well-known functions or constructions may not be described in detail for brevity and/or clarity.
(36) It will be understood that when an element is referred to as being “on,” “attached” to, “connected” to, “coupled” with, “contacting,” etc., another element, it can be directly on, attached to, connected to, coupled with and/or contacting the other element or intervening elements can also be present. In contrast, when an element is referred to as being, for example, “directly on,” “directly attached” to, “directly connected” to, “directly coupled” with or “directly contacting” another element, there are no intervening elements present. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature can have portions that overlap or underlie the adjacent feature.
(37) Spatially relative terms, such as “under,” “below,” “lower,” “over,” “upper” and the like, may be used herein for ease of description to describe an element's or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if the. device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus the exemplary term “under” can encompass both an orientation of over and under. The device may otherwise be oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly,” “downwardly,” “vertical,” “horizontal” and the like are used herein for the purpose of explanation only, unless specifically indicated otherwise.
(38) It will be understood that, although the terms first, second, etc., may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be limited by these terms. Rather, these terms are only used to distinguish one element, component, region, layer and/or section, from another element, component, region, layer and/or section. Thus, a first element, component, region, layer or section discussed herein could be termed a second element, component, region, layer or section without departing from the teachings of the present invention. The sequence of operations (or steps) is not limited to the order presented in the claims or figures unless specifically indicated otherwise.
(39) “Botulinum toxin” as used herein may be any suitable, pharmaceutically acceptable, and generally liquid injectible, formulation thereof, such as BOTOX® onabotulinumtoxin A from Allergan Inc.
(40)
(41) The first open end or outlet port 14 may take any suitable form, such as a LEVER taper fitting, a LEVER-LOCK™ fitting, etc.
(42) The syringe body may include laterally extending finger or gripping tabs 15, which are optionally but preferably positioned near the second (wider) open end (e.g., within 1 or 2 millimeters thereof).
(43) The plunger itself comprises a plunger shaft 20, which is formed of one or more plunger ribs 21 (four ribs in the embodiment of
(44) As best shown in
(45) As shown in
(46)
(47)
(48)
(49)
(50)
(51)
(52)
(53) In all of the foregoing, the plunger or elongate shaft may comprise or consist of an organic polymer (e.g., polypropylene). Likewise, the hollow body may comprise or consist of an organic polymer (e.g., polypropylene). The seal (not shown) may also be formed of an organic polymer, but generally a different material, that is elastic, such as natural or synthetic rubber or a thermoplastic elastomer (TPE).
(54) In all of the foregoing, the syringe may having a total injectable volume of from 1 or 2 milliliters to 5, 10 or 30 milliliters, or more, with the first set of detents (and when present said second set of detents) configured to divide said total injectable volume into at least 5, 10 or 20 uniform injectable subvolumes, and up to 40 or 50 uniform injectable subvolumes. Optionally but preferably, each of injectable subvolumes are not more than 1, 2, 5 or 10 percent different from one another.
(55) Any of the foregoing syringes may be loaded with any suitable pharmaceutical formulation, such as a sterile injectable pharmaceutical formulation (e.g. a formulation comprising botulinum toxin or lidocaine in a pharmaceutically acceptable aqueous carrier) contained therein. In some embodiments, an injection needle (optionally with a removable or retractable cover to help minimize inadvertent “needle sticks”) may be fixed to or operatively associated with the outlet opening. Depending on the intended use, a rigid or flexible endoscope (e.g., a cystoscope) or guide cannula may be operatively coupled to the syringe outlet opening.
(56) While the invention has been described above substantially as a combination of a syringe plunger with a syringe barrel and seal, it will be appreciated that the syringe plunger may be provided as a subcombination part alone, useful for subsequent assembly into a complete syringe as described herein.
(57) The foregoing is illustrative of the present invention, and is not to be construed as limiting thereof. The invention is defined by the following claims, with equivalents of the claims to be included therein.